-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Evelo Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q3 2023.
- Evelo Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$1.2M, a 14.6% increase year-over-year.
- Evelo Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was -$4.7M, a 11.5% decline year-over-year.
- Evelo Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was -$5.13M, a 19.2% increase from 2021.
- Evelo Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was -$6.35M, a 363% decline from 2020.
- Evelo Biosciences, Inc. annual Nonoperating Income (Expense) for 2020 was -$1.37M, a 228% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)